A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.

作者: Patricia Price , Niamh M. Keane , Silvia Lee , Andrew F. Y. Lim , Elizabeth J. McKinnon

DOI: 10.1111/J.1365-2567.2006.02407.X

关键词:

摘要: Low-level production of interferon-γ (IFN-γ) marks human immunodeficiency virus (HIV)-induced and has been ascribed to a bias towards T2 cytokines. This was investigated in two cross-sectional studies HIV patients who were immunodeficient when they began antiretroviral therapy (ART) had stable increases CD4 T-cell counts. Blood leucocytes assessed unstimulated or after stimulation with cytomegalovirus (CMV), anti-CD3 mitogen. IFN-γ interleukin (IL)-5 responses initially by enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) (ELISA). We then adopted sensitive reverse transcription–polymerase chain reaction (RT–PCR) system assess IFN-γ, IL-5, IL-4 IL-4δ2 (an inhibitory splice variant IL-4) mRNA. The results correlated putative serological markers T1 [lymphocyte activation gene-3 (LAG-3), CD26] [CD30, immunoglobulin E (IgE)] cytokine environment. IL-5 IgE levels elevated patients. did not correlate but showed an inverse correlation released culture (P = 0·05). IL-4, mRNA stimulation, where the best predictor 0·006). Weak positive correlations evident between CD30 levels, whilst inversely IL-4δ2, levels. These analyses provide no evidence for relationship patients, suggest that elevation low responses.

参考文章(43)
Yojiro Arinobu, Sergei P. Atamas, Takeshi Otsuka, Hiroaki Niiro, Kunihiro Yamaoka, Hiromichi Mitsuyasu, Yoshiyuki Niho, Naotaka Hamasaki, Barbara White, Kenji Izuhara, Antagonistic Effects of an Alternative Splice Variant of Human IL-4, IL-4δ2, on IL-4 Activities in Human Monocytes and B Cells Cellular Immunology. ,vol. 191, pp. 161- 167 ,(1999) , 10.1006/CIMM.1998.1431
Maria C. Villacres, Oana Literat, Marina Degiacomo, Wenbo Du, Corinna La Rosa, Don J. Diamond, Andrea Kovacs, Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV. Journal of Clinical Immunology. ,vol. 25, pp. 134- 141 ,(2005) , 10.1007/S10875-005-2819-X
Byoung-gon Moon, Satoshi Takaki, Hirofumi Nishizumi, Tadashi Yamamoto, Kiyoshi Takatsu, Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor α chain gene Cellular Immunology. ,vol. 228, pp. 110- 118 ,(2004) , 10.1016/J.CELLIMM.2004.04.005
Salvador Resino, Laura Rivero, Ezequiel Ruiz-Mateos, Isabel Galán, Jaime Munoz Franco, Ma. Ángeles Munoz-Fernández, Manuel Leal, Immunity in HIV-1-infected adults with a previous state of moderate-severe immune-suppression and more than 500 CD4+ T cell after highly active antiretroviral therapy. Journal of Clinical Immunology. ,vol. 24, pp. 379- 388 ,(2004) , 10.1023/B:JOCI.0000029112.82425.59
Philip G. Hargreaves, Aymen Al-Shamkhani, Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30. European Journal of Immunology. ,vol. 32, pp. 163- 173 ,(2002) , 10.1002/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T
Keertan Dheda, Jung-Su Chang, Ronan A. M. Breen, Louise U. Kim, Jamanda A. Haddock, Jim F. Huggett, Margaret A. Johnson, Graham A. W. Rook, Alimuddin Zumla, In Vivo and In Vitro Studies of a Novel Cytokine, Interleukin 4δ2, in Pulmonary Tuberculosis American Journal of Respiratory and Critical Care Medicine. ,vol. 172, pp. 501- 508 ,(2005) , 10.1164/RCCM.200502-278OC